Burhan Başkan

Dr. Burhan Başkan

Ophthalmology, Health Sciences University, Van Training and Research Hospital, Van, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
BBBurhan Başkan
Burhan Başkan
ACAyşe Cıcek
Ayşe Cıcek
AGAhmet Gulhan
Ahmet Gulhan
MGMedine Gundogan
Medine Gundogan
SGSertan Goktas
Sertan Goktas
To report the therapeutic efficacy and results of an accidentally injected intralenticular sustained-release dexamethasone implant (Ozurdex) in a patient with macular edema secondary to central retinal vein occlusion at 14 months after injection. We present a 70-year-old female patient with central retinal vein occlusion who underwent an Ozurdex injection. Patient discontinued from the treatment period during the 14-month and there was no ophthalmologic examination of the patient. Detailed ophthalmological examination was performed. Ozurdex localization was determined by Pentacam rotating Scheimpflug System. The implant was accidentally injected into the crystalline lens. It did not cause a totally lens opacification but did result only in a posterior subcapsular cataract. The macular edema did not resolve, and the patient underwent phacoemulsification surgery. Ozurdex that totally located inside the crystallize lens may not have the therapeutic effects.

11 September 2024 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
BBBurhan Başkan
Burhan Başkan
MAMustafa Atas
Mustafa Atas
SDSuleyman Demircan
Suleyman Demircan

2 November 2025 in Güncel Retina Dergisi (Current Retina Journal)
Verified
Journal Article
Open access
PDF file
BBBurhan Başkan
Burhan Başkan
Age-related macular degeneration (AMD) is a multifaceted and complex disorder caused by a combination of genetic predisposition and environmental factors. The continuous unearthing of links between genetic variation and AMD supports the critical importance of genes in the development of this disease. Accordingly, genetic tests and polygenic scoring have been developed to predict the tendency and response to treatment. However, the effectiveness of these methods has not yet been proven. Moreover, there is no clinical data to suggest that studying an individual's genetic makeup improves treatment outcomes. This detailed review summarizes the genetic variations in the main pathogenetic pathways that may be promising therapeutic targets. Since overactivation of the complement system plays an important role, interventions targeting complement proteins are considered a promising treatment approach. Here, we will focus on molecules that regulate the complement system and are currently in clinical trials, especially those in advanced stages. Gene therapy stands out as a revolutionary, one-time treatment option, and its importance in the field of retinal diseases is rapidly increasing. For this reason, we will discuss the current status of gene therapies with both complement suppressor and anti-VEGF effects in clinical trials.

20 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BBBurhan Başkan
Burhan Başkan
YEYUSUF EVCİMEN
YUSUF EVCİMEN
Objectives: To determine whether the superior anatomical control achieved with a treat-and-extend (T&E) anti-VEGF regimen translates into better five-year visual outcomes than a pro re nata (PRN) regimen in treatment-naïve center-involving diabetic macular edema (CI-DME), and to characterize the anatomical–functional relationship. Methods: In this retrospective propensity-score–matched survivor cohort, one eye per patient was analyzed. One-to-one nearest-neighbor matching balanced 14 baseline covariates. Longitudinal best-corrected visual acuity (BCVA) and central subfield thickness (CST) were analyzed using linear mixed-effects models with matched-pair clustering. Absence of a clinically meaningful visual difference was evaluated using two one-sided tests (TOST) with a prespecified ±5-letter equivalence margin. The anatomical–functional relationship was assessed by segmented regression. Sensitivity analyses included inverse probability of treatment weighting, doubly robust estimation, inverse probability of censoring weighting, best-/worst-case imputation, interval-censored recurrence modeling, and E-value analysis. Results: Both regimens improved BCVA, with no clinically meaningful difference at five years (T&E +6.2 ± 14.6 vs. PRN +6.9 ± 14.0 letters; difference −0.7 letters; 90% CI, −2.4 to 1.0; TOST p < 0.001). T&E achieved greater CST reduction (−172.3 vs. −114.2 µm; difference −58.1 µm; p < 0.001), higher dry-macula rates (73.8% vs. 59.5%; p < 0.001), fewer recurrences (2.2 vs. 3.9; p < 0.001), and fewer monitoring-only visits (14.6 vs. 28.4; p < 0.001), but required 53% more injections (25.1 vs. 16.4; p < 0.001). Segmented regression identified a breakpoint at 148 µm CST reduction; additional thinning beyond this threshold was not associated with further visual improvement. Baseline BCVA, ellipsoid zone disruption, and diabetic retinopathy severity, but not treatment regimen, independently predicted five-year vision. Results were consistent across sensitivity analyses. Conclusions: Among patients completing five years of therapy, additional anatomical drying beyond an exploratory, cohort-specific breakpoint of approximately 150 µm CST reduction was not associated with further measurable visual gain in this observational cohort. Regimen selection should therefore reflect treatment burden, monitoring requirements, and patient preference rather than anticipated visual superiority. Because the cohort included only patients completing five years of follow-up, these findings apply to adherent patients and should not be generalized to unselected populations.

22 February 2026 in JMIR Preprints
Verified
Preprint
Open access
BBBurhan Başkan
Burhan Başkan
BACKGROUND Large language models (LLMs) have demonstrated remarkable performance on medical licensing examinations, particularly in English-language contexts. However, little research has systematically evaluated their capabilities in non-English languages, especially morphologically complex languages like Turkish. Furthermore, the risk of data contamination in studies using publicly available exam questions remains inadequately addressed, and comparative analyses across multiple state-of-the-art models from both closed and open-source ecosystems are lacking in the ophthalmology literature. OBJECTIVE This study aimed to comprehensively evaluate the performance of seven leading LLMs from the 2024-2025 period on Turkish Medical Specialty Examination (TUS) ophthalmology questions, analyzing factors such as question type (case-based vs. knowledge-based), chronological question age (2015-2019 vs. 2020-2024), and clinical subspecialty, while critically assessing the risk of data contamination and the technology's realistic potential in medical education. METHODS A set of 210 TUS ophthalmology questions (2015-2024) was presented to seven LLMs (OpenAI o1-preview, Claude 4.5 Sonnet, GPT-4o, Gemini 2.5 Pro, DeepSeek-R1, Llama 3 70B, Command R+) using a standardized Turkish prompt template between November-December 2024. All responses underwent blinded, expert qualitative coding by two experienced ophthalmologists for accuracy, explanation quality (1-3 Likert), confidence level (1-3 Likert), and error type (conceptual error, hallucination, inattentiveness). Statistical analyses included chi-square tests for inter-model comparisons, independent samples t-tests for closed versus open-source model groups, odds ratio calculations, and Spearman correlation for confidence-accuracy relationships. RESULTS OpenAI o1-preview achieved the highest overall accuracy (95.2%, 200/210), followed by Claude 4.5 Sonnet (93.8%) and GPT-4o (91.9%). Notably, all three models demonstrated 100% accuracy on clinical case-based questions (n=105). A significant performance gap existed between closed-source (average 91.0%) and open-source models (average 66.1%) (p<0.001, OR=5.14, 95% CI: 2.58-10.22). Chronological analysis revealed substantial performance declines on new questions (2020-2024) for models with older knowledge cutoff dates: Command R+ (-22.9%), DeepSeek-R1 (-14.3%), and Gemini 2.5 Pro (-8.6%), suggesting potential data contamination. Qualitative analysis showed error concentration (over 65%) in complex clinical areas including glaucoma (28.7%) and retina (23.2%). Hallucination rates were substantially higher in open-source models (42.5% vs. 12.8% in closed-source models). A weak, non-significant correlation was found between model confidence and answer accuracy (Spearman ρ=0.21, p=0.09), indicating a "confident incorrectness" paradox. CONCLUSIONS Advanced closed-source LLMs demonstrate near-expert-level textual performance on Turkish TUS ophthalmology questions, highlighting their potential as complementary educational tools for exam preparation and case-based learning. However, significant performance variations between model types, vulnerabilities in nuanced clinical judgment (particularly in glaucoma and retina subspecialties), suspected data contamination in older models, high hallucination rates in open-source models, and the confidence-accuracy disconnect necessitate a critical approach with continuous human oversight. This text-based performance must not be equated with real-world, visually-intensive clinical diagnostic competence. Implementation requires rigorous validation protocols, AI literacy education for clinicians and students, and clear ethical frameworks, with ultimate authority remaining with the human expert. Future research should evaluate multimodal LLMs' visual diagnostic capabilities and conduct fine-tuning studies with Turkish ophthalmology datasets.

31 July 2026 in Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Closed access
BBBurhan Başkan
Burhan Başkan
YEYUSUF EVCİMEN
YUSUF EVCİMEN
ÖTÖzgür Bülent Timuçin
Özgür Bülent Timuçin
İYİffet Yarımağa
İffet Yarımağa
CSCelal Sağmış
Celal Sağmış
This study aimed to comprehensively evaluate the performance of seven leading large language models (LLMs) from the 2024-2025 period on Turkish Medical Specialty Examination (TUS) ophthalmology questions, analyzing factors such as question type, chronology, and clinical area, while critically assessing the risk of data contamination and the technology's realistic potential in medical education. A set of 210 TUS ophthalmology questions (2015-2024) was presented to seven LLMs (OpenAI o1-preview, Claude 4.5 Sonnet, GPT-4o, Gemini 2.5 Pro, DeepSeek-R1, Llama 3 70B, Command R+) using a standardized protocol. Performance was statistically compared based on overall accuracy, question type (case-based vs. knowledge-based), chronological period (old: 2015-2019 vs. new: 2020-2024), and clinical subspecialty. All responses underwent blinded, expert qualitative coding for error type and confidence. OpenAI o1-preview achieved the highest overall accuracy (95.2%). Claude 4.5 Sonnet and GPT-4o demonstrated 100% accuracy on case-based questions. A significant performance gap existed between closed-source (average 91.0%) and open-source models (average 66.1%) (p